Cover Image

Efficacy and safety of the combination of tirabrutinib and entospletinib with or without obinutuzumab in relapsed chronic lymphocytic leukemia

Saved in:
Bibliographic Details
Main Authors: Kutsch, Nadine (Author) , Pallasch, Christian (Author) , Tausch, Eugen (Author) , Böhme, Volkmar (Author) , Ritgen, Matthias (Author) , Liersch, Rüdiger (Author) , Wacker, Alexander (Author) , Jacobs, Georg (Author) , Trappe, Ralf Ulrich (Author) , Dreger, Peter (Author) , Fischer, Kirsten (Author) , Fink, Anna-Maria (Author) , Stilgenbauer, Stephan (Author) , Zhai, Shuyan (Author) , Li, Biao (Author) , Jürgensmeier, Juliane M. (Author) , Rajakumaraswamy, Nishanthan (Author) , Bhargava, Pankaj (Author) , Hallek, Michael (Author) , Eichhorst, Barbara (Author)
Format: Article (Journal) Editorial
Language:English
Published: Mar 8, 2022
In: HemaSphere
Year: 2022, Volume: 6, Issue: 4, Pages: 1-4
ISSN:2572-9241
DOI:10.1097/HS9.0000000000000692
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/HS9.0000000000000692
Get full text
Author Notes:Nadine Kutsch, Christian Pallasch, Eugen Tausch, Volkmar Böhme, Matthias Ritgen, Rüdiger Liersch, Alexander Wacker, Georg Jacobs, Ralf Ulrich Trappe, Peter Dreger, Kirsten Fischer, Anna-Maria Fink, Stephan Stilgenbauer, Shuyan Zhai, Biao Li, Juliane M. Jürgensmeier, Nishanthan Rajakumaraswamy, Pankaj Bhargava, Michael Hallek, Barbara F. Eichhorst
Description
Item Description:Gesehen am 07.04.2022
Physical Description:Online Resource
ISSN:2572-9241
DOI:10.1097/HS9.0000000000000692

Similar Items